Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-155713
Filing Date
2014-04-24
Accepted
2014-04-24 06:07:52
Documents
1
Period of Report
2014-05-29
Effectiveness Date
2014-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d710875ddef14a.htm DEF 14A 625136
  Complete submission text file 0001193125-14-155713.txt   626267
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 14780025
SIC: 2835 In Vitro & In Vivo Diagnostic Substances